Fig. 2From: Reduced doses of dabrafenib and trametinib combination therapy for BRAF V600E-mutant non-small cell lung cancer prevent rhabdomyolysis and maintain tumor shrinkage: a case reportComputed tomography images of NSCLC. These images show maintained tumor shrinkage after reducing the doses of dabrafenib and trametinibBack to article page